Vicarious Surgical Inc. (NYSE:RBOT) Short Interest Down 32.3% in December

Vicarious Surgical Inc. (NYSE:RBOT) saw a significant decline in short interest in December. As of December 31st, there was short interest totaling 140,432 shares, a decline of 32.3% from the December 15th total of 207,502 shares. Currently, 2.4% of the shares of the company are sold short. Based on an average daily volume of 110,484 shares, the days-to-cover ratio is presently 1.3 days. Based on an average daily volume of 110,484 shares, the days-to-cover ratio is presently 1.3 days. Currently, 2.4% of the shares of the company are sold short.

Wall Street Analysts Forecast Growth

Several brokerages have commented on RBOT. Weiss Ratings restated a “sell (e+)” rating on shares of Vicarious Surgical in a research note on Wednesday, October 8th. Wall Street Zen raised shares of Vicarious Surgical from a “sell” rating to a “hold” rating in a report on Saturday, January 10th. Finally, BTIG Research restated a “neutral” rating on shares of Vicarious Surgical in a research report on Friday, December 12th. Two research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Reduce” and a consensus price target of $7.00.

Vicarious Surgical Price Performance

Shares of NYSE:RBOT traded down $0.19 on Friday, hitting $2.68. The company’s stock had a trading volume of 79,954 shares, compared to its average volume of 175,721. The company has a market capitalization of $17.52 million, a PE ratio of -0.30 and a beta of 1.52. The company has a 50-day simple moving average of $2.71 and a 200 day simple moving average of $5.53. Vicarious Surgical has a 1 year low of $1.80 and a 1 year high of $16.92.

Vicarious Surgical (NYSE:RBOT) last issued its quarterly earnings data on Wednesday, November 12th. The company reported ($1.91) EPS for the quarter, topping the consensus estimate of ($2.37) by $0.46. On average, equities research analysts expect that Vicarious Surgical will post -10.89 earnings per share for the current fiscal year.

Institutional Trading of Vicarious Surgical

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Dimensional Fund Advisors LP grew its position in Vicarious Surgical by 22.1% in the third quarter. Dimensional Fund Advisors LP now owns 19,975 shares of the company’s stock worth $110,000 after acquiring an additional 3,615 shares in the last quarter. DNB Asset Management AS raised its position in Vicarious Surgical by 12.1% during the second quarter. DNB Asset Management AS now owns 29,199 shares of the company’s stock valued at $219,000 after purchasing an additional 3,154 shares in the last quarter. Finally, Connective Capital Management LLC bought a new stake in Vicarious Surgical during the third quarter worth about $169,000. Hedge funds and other institutional investors own 47.27% of the company’s stock.

Vicarious Surgical Company Profile

Vicarious Surgical develops a next-generation robotic surgical system that integrates virtual reality (VR) with minimally invasive instrumentation. Its flagship offering combines ultra-slender, articulated robotic arms with a VR surgeon console, allowing physicians to perform laparoscopic procedures with enhanced precision, dexterity and visual immersion. The platform is designed to reduce patient trauma compared with traditional open or laparoscopic surgery and to expand surgeon access to challenging operative sites.

The company’s technology is intended for use across multiple surgical specialties, including general surgery, gynecology and urology.